亚博app

爱尔眼科简介

分享到:

爱尔眼科病院团体是中国及环球范围病院范围和医疗才能的眼科医疗团体,笼盖亚洲、欧洲和北美洲,在中国际地、欧洲、西北亚具有3家上市公司(中国深圳:爱尔眼科,300015;西班牙:CBAV;新加坡:40T),眼科病院及中间数目达600余家,此中中国际地500余家、中国香港7家、美国1家、欧洲80余家,西北亚12家,中国际地年门诊量超1000万人次。

AIER Eye Hospital Group is China’s leading ophthalmology hospital group that covers Asia, Europe, and North America with huge scale and outstanding medical capacity. It has three listed companies in China (stock code: 300015) ,Europe (Spain: CBAV), and Southeast Asia (Singapore: 40T) with a total number of more than 600 specialized eye hospitals and centers and the annual outpatient visits in mainland China exceeded 10 million. Among those eye hospitals and centers, there are more than 500 in Mainland China, 7 in Hong Kong, 1 in the United States, more than 80 in Europe, and 12 in Southeast Asia.

爱尔眼科努力于引进和接收国际同步的眼科手艺与医疗办理理念,以专业化、范围化、迷信化为成长计谋,鞭策中国眼科医疗奇迹的成长。

AIER is committed to the parallel introduction and absorption of world-leading ophthalmic technology and management concept, with professionalism, scale and science as its strategy to advance China's ophthalmic medical care.

经由进程不时的摸索与理论,并充实吸纳国际的医疗办理经历的根本上,胜利摸索出一套适应中国国情和市场情况的眼科病院连锁运营办理形式——“分级连锁”。操纵人材、手艺和办理等方面的上风,经由进程天下各连锁病院杰出的诊疗品德、优良的医疗办事和杰出的医患相同,使爱尔眼科成为天下各地眼科患者相信的眼科病院。

Base on constant exploration and practice, also with absorbing advanced international medical management experience, AIER Eye Hospital Group has successfully established the "hierarchical chain" management model that adapts to China's market environment. Utilizing our advantages in talent, technology and management, we aim to provide the most trusted eye care to patients all over the country by offering good medical quality, superior medical service and harmonious doctors-to-patients communication.

2013年,爱尔眼科病院团体与中南大学结合建立专业的眼科医学院——中南大学爱尔眼迷信院,首要培育眼科硕、博士精英医疗人材,开启了社会本钱到场医学教导的无益立异和摸索;

2014年,与湖北科技大学结合建立爱尔眼视光学院,旨在培育眼视光学的专业手艺人材。

2019年,新增武汉大学爱尔眼科临床学院及研讨院。

与此同时,自2015年爱尔眼科前后建立爱尔眼科研讨所、爱尔眼视光研讨所、角膜病研讨所、白内障研讨所、青光眼研讨所、视网膜研讨所和屈光研讨所等7大研讨所,旨在鞭策眼迷信、视觉迷信和各亚专科前沿和临床利用手艺的研讨和立异。

爱尔眼科经由进程建立学院和研讨所等机构,正式买通了眼科的医、学、研三大范畴,使爱尔眼科的科研及临床程度获得明显晋升,并以此鞭策中国眼科医疗奇迹的成长和前进。

In 2013, AIER and Central South University jointly set up AIER School of Ophthalmology, CSU, to educate and train medical professionals with advanced degrees,which opened a new era for social capital to be involved in medical education.

In 2014, AIER joined the Hubei University of Science and Technology to establish the AIER School of Ophthalmology & Optometry, which aims to cultivate specialized talents in Optometry.

In 2019, AIER Clinical College of Ophthalmology, and Ophthalmic Research Institute in Wuhan University were found.

Besides, AIER has established 7 institutes since 2011, they are AIER Ophthalmology Institute, AIER Optometry Institute, AIER Refraction Institute, AIER Corneal Institute, AIER Glaucoma Institute, AIER Retinology Institute, and AIER Cataract Institute.

At this point, AIER has bridged all three areas of medicine, education, and research, the establishment of these educational and research institutions will significantly boost our research and clinical standards.

在疾速逾越式成长的进程中,爱尔眼科凝集和培育了一批经历丰硕、开辟立异的办理团队和医术精巧、治学松散的眼科专家和大夫团队。停止2020年4月,爱尔眼科团体及旗下环球员工总数 36,000余人,此中眼科及视光大夫总数(含海内)7,400余人,包含一多量硕士生导师、博士生导师、博士、博士后、留学西欧的学者和临床经历丰硕的焦点专家,是中国眼科范畴备受注视的有生气力。

In the process of rapid development, AIER has gathered and cultivated a group of experienced and innovative management team and a team of ophthalmologists with excellent medical ability and rigorous academic background. As of April, 2020,AIER has more than 36,000 employees globally, including 7,400 ophthalmologists and optometrists. Ophthalmologists in AIER consist of a large number of Master's supervisor, PH.D supervisor, Ph.D, Post doctorates, scholars trained in Europe and the United States and core experts with rich clinical experience. They are a high-profile core force in the field of ophthalmology in China.

爱尔眼科的成长强大,一直以“使一切人,不管贫困敷裕,都享有眼安康的权力”为任务,寻求社会义务和本身成长的协调同一,经由进程首创性的“穿插补贴”形式,一方面为患者供给更高品德的眼科医疗办事,同时周全展开防盲治盲任务、投身社会公益和赞助弱势群体,并结合社会各界,鞭策全部中国防盲奇迹甚至公民眼安康奇迹的周全成长。

Since its founding, AIER always committed to the mission,“Enabling everyone, whether rich or poor, has the right to eye health.”With its "cross-subsidy" model, AIER provides patients with higher quality services, in the meantime dedicate itself to the social welfare and helping vulnerable groups to promote the cause of fighting blindness and national eye health.

跟着中国医疗卫生体系体例鼎新的进一步鞭策,爱尔眼科适应国度医疗卫生政策和成长趋向,当令在医疗行业推出“合股人打算”,努力于转变眼科大夫执业的生态情况,限制地激起焦点主干的缔造力和能动性,为鞭策公司范围与效益的同步进步注入延续成长的关头能源。爱尔眼科专一于眼科医疗办事奇迹,将在天下的城乡县域兴修各级专业连锁眼科病院,为更多的人供给高品德、多条理的眼科医疗办事。

With the reform on China's medical health system, AIER adapts to the national medical policy and trend, launching the "Partnership Program" in the healthcare industry to focus on changing the ecological environment for ophthalmologists and maximizing the creativity and initiative of core members in 2014. This strategy is a strong motivation for expanding AIER’s scale, raising benefits. AIER has always been focusing on eye care service and will establish more professional hospitals in smaller cities and counties providing high quality and multi-level eye care to more people.

微信定阅爱尔眼科
请存眷公家号:aierhospital ,爱眼护眼早晓得。